Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Chronic Heart Failure

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 124 articles:
HTML format
Text format



Single Articles


    August 2018
  1. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Text format     Abstract available


    July 2018
  2. LYON AR
    Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.
    Heart. 2018 Jul 4. pii: heartjnl-2018-313493. doi: 10.1136/heartjnl-2018-313493.
    PubMed     Text format    


  3. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed     Text format    


    June 2018
  4. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed     Text format    


    May 2018
  5. NG AT, Duan L, Win T, Spencer HT, et al
    Maternal and fetal outcomes in pregnant women with heart failure.
    Heart. 2018 May 25. pii: heartjnl-2018-313156. doi: 10.1136/heartjnl-2018-313156
    PubMed     Text format     Abstract available


  6. NADRUZ W JR, West E, Sengelov M, Grove GL, et al
    Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.
    Heart. 2018 May 15. pii: heartjnl-2018-313234. doi: 10.1136/heartjnl-2018-313234
    PubMed     Text format     Abstract available


    April 2018
  7. ROHDE LE, Beck-da-Silva L
    Alcohol and the heart: the good, the bad and the worse in heart failure.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312924. doi: 10.1136/heartjnl-2017-312924.
    PubMed     Text format    


    March 2018
  8. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910
    PubMed     Text format    


  9. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Text format     Abstract available


  10. NADRUZ W JR, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, et al
    Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Heart. 2018 Mar 9. pii: heartjnl-2017-312869. doi: 10.1136/heartjnl-2017-312869.
    PubMed     Text format     Abstract available


  11. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed     Text format    


    February 2018
  12. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed     Text format    


    January 2018
  13. WITTE KK, Patel PA, Walker AMN, Schechter CB, et al
    Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.
    Heart. 2018 Jan 31. pii: heartjnl-2017-312539. doi: 10.1136/heartjnl-2017-312539
    PubMed     Text format     Abstract available


  14. SQUIRE I
    Socioeconomic status and outcomes in heart failure with reduced ejection fraction.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312814. doi: 10.1136/heartjnl-2017-312814
    PubMed     Text format    


  15. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Text format     Abstract available


  16. WANG YC, Huang CW, Lin TW
    Acute heart failure with new-onset continuous murmur in a 26-year-old man.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312506. doi: 10.1136/heartjnl-2017-312506
    PubMed     Text format     Abstract available


  17. ZAKERI R, Cowie MR
    Heart failure with preserved ejection fraction: controversies, challenges and future directions.
    Heart. 2018 Jan 5. pii: heartjnl-2016-310790. doi: 10.1136/heartjnl-2016-310790.
    PubMed     Text format     Abstract available


    December 2017
  18. MCMURRAY JJV, Trueman D, Hancock E, Cowie MR, et al
    Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
    Heart. 2017 Dec 21. pii: heartjnl-2016-310661. doi: 10.1136/heartjnl-2016-310661
    PubMed     Text format     Abstract available


  19. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Text format     Abstract available


  20. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Text format     Abstract available


  21. RAO P, Faddis M
    Cardiac resynchronisation therapy: current indications, management and basic troubleshooting.
    Heart. 2017;103:2000-2007.
    PubMed     Text format    


    November 2017
  22. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Text format     Abstract available


  23. MORTON G, Masters J, Cowburn PJ
    Multidisciplinary team approach to heart failure management.
    Heart. 2017 Nov 23. pii: heartjnl-2016-310598. doi: 10.1136/heartjnl-2016-310598
    PubMed     Text format    


  24. HUTCHINGS DC, Anderson SG, Trafford AW
    Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Heart. 2017;103:1745.
    PubMed     Text format    


    October 2017
  25. LEE H, Lee SE, Park CS, Park JJ, et al
    Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction.
    Heart. 2017 Oct 27. pii: heartjnl-2017-312084. doi: 10.1136/heartjnl-2017-312084
    PubMed     Text format     Abstract available


  26. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Heart. 2017 Oct 5. pii: heartjnl-2017-311813. doi: 10.1136/heartjnl-2017-311813.
    PubMed     Text format     Abstract available


  27. BOTTLE A, Kim D, Aylin P, Cowie MR, et al
    Routes to diagnosis of heart failure: observational study using linked data in England.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312183. doi: 10.1136/heartjnl-2017-312183.
    PubMed     Text format     Abstract available


  28. PETRIE MC, Rocchiccioli P
    Coronary angiography in heart failure: when and why? Uncertainty reigns.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312200. doi: 10.1136/heartjnl-2017-312200.
    PubMed     Text format    


  29. SINGH JSS, Burrell LM, Cherif M, Squire IB, et al
    Sacubitril/valsartan: beyond natriuretic peptides.
    Heart. 2017;103:1569-1577.
    PubMed     Text format     Abstract available


  30. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Text format     Abstract available


    August 2017
  31. SCHNELL F, Donal E
    Pharmacological strategies in heart failure with preserved ejection fraction: time for an individualised treatment strategy?
    Heart. 2017 Aug 18. pii: heartjnl-2017-312119. doi: 10.1136/heartjnl-2017-312119
    PubMed     Text format    


  32. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    PubMed     Text format     Abstract available


  33. ZHENG SL, Chan FT, Nabeebaccus AA, Shah AM, et al
    Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311652. doi: 10.1136/heartjnl-2017-311652.
    PubMed     Text format     Abstract available


    July 2017
  34. TUEGEL C, Bansal N
    Heart failure in patients with kidney disease.
    Heart. 2017 Jul 17. pii: heartjnl-2016-310794. doi: 10.1136/heartjnl-2016-310794
    PubMed     Text format     Abstract available


  35. SCHMIDT M
    Interaction between body mass index and physical fitness in primary heart failure prevention.
    Heart. 2017 Jul 17. pii: heartjnl-2017-311504. doi: 10.1136/heartjnl-2017-311504
    PubMed     Text format    


  36. MINAMINO-MUTA E, Kato T, Morimoto T, Taniguchi T, et al
    Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
    Heart. 2017 Jul 6. pii: heartjnl-2016-311022. doi: 10.1136/heartjnl-2016-311022.
    PubMed     Text format     Abstract available


  37. D'AMARIO D, Amodeo A, Adorisio R, Tiziano FD, et al
    A current approach to heart failure in Duchenne muscular dystrophy.
    Heart. 2017 Jul 1. pii: heartjnl-2017-311269. doi: 10.1136/heartjnl-2017-311269.
    PubMed     Text format     Abstract available


  38. GROGAN M, Dispenzieri A, Gertz MA
    Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Heart. 2017;103:1065-1072.
    PubMed     Text format     Abstract available


    June 2017
  39. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed     Text format    


  40. ROHDE LE, Biolo A
    The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure.
    Heart. 2017 Jun 5. pii: heartjnl-2017-311558. doi: 10.1136/heartjnl-2017-311558.
    PubMed     Text format    


    May 2017
  41. CRUMP C, Sundquist J, Winkleby MA, Sundquist K, et al
    Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
    Heart. 2017 May 12. pii: heartjnl-2016-310716. doi: 10.1136/heartjnl-2016-310716
    PubMed     Text format     Abstract available


  42. CARLSON S, Duber HC, Achan J, Ikilezi G, et al
    Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
    Heart. 2017 May 10. pii: heartjnl-2016-310913. doi: 10.1136/heartjnl-2016-310913
    PubMed     Text format     Abstract available


  43. KUTYIFA V
    Gender-specific outcomes of cardiac resynchronisation therapy with or without defibrillator.
    Heart. 2017;103:732-733.
    PubMed     Text format    


  44. OTTO CM
    Heartbeat: Cardiac resynchronization therapy with or without defibrillation: are women different?
    Heart. 2017;103:727-728.
    PubMed     Text format    


    April 2017
  45. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Text format     Abstract available


    March 2017
  46. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.
    PubMed     Text format    


  47. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.
    PubMed     Text format    


    February 2017
  48. ROSMINI S, Biagini E, O'Mahony C, Bulluck H, et al
    Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Heart. 2017;103:300-306.
    PubMed     Text format     Abstract available


    January 2017
  49. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    PubMed     Text format     Abstract available


    December 2016
  50. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    PubMed     Text format     Abstract available


  51. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    PubMed     Text format     Abstract available


  52. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.
    PubMed     Text format    


  53. BURCHILL LJ
    Heart transplantation in adult congenital heart disease.
    Heart. 2016;102:1871-1877.
    PubMed     Text format     Abstract available


    November 2016
  54. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191
    PubMed     Text format    


    October 2016
  55. CHIMURA M, Onishi T, Tsukishiro Y, Sawada T, et al
    Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Heart. 2016 Oct 31. pii: heartjnl-2016-309746. doi: 10.1136/heartjnl-2016-309746
    PubMed     Text format     Abstract available


  56. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039
    PubMed     Text format    


  57. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536
    PubMed     Text format    


  58. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Text format     Abstract available


  59. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Text format     Abstract available


    September 2016
  60. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336
    PubMed     Text format    


  61. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Text format     Abstract available


  62. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    PubMed     Text format     Abstract available


  63. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    PubMed     Text format     Abstract available


  64. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Text format     Abstract available


  65. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    PubMed     Text format     Abstract available


  66. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    PubMed     Text format     Abstract available


    August 2016
  67. EMDIN CA, Conrad N, Kiran A, Salimi-Khorshidi G, et al
    Variation in hospital performance for heart failure management in the National Heart Failure Audit for England and Wales.
    Heart. 2016 Aug 16. pii: heartjnl-2016-309706. doi: 10.1136/heartjnl-2016-309706
    PubMed     Text format     Abstract available


  68. OSENI AO, Qureshi WT, Almahmoud MF, Bertoni AG, et al
    Left ventricular hypertrophy by ECG versus cardiac MRI as a predictor for heart failure.
    Heart. 2016 Aug 2. pii: heartjnl-2016-309516. doi: 10.1136/heartjnl-2016-309516.
    PubMed     Text format     Abstract available


    July 2016
  69. MEALING S, Woods B, Hawkins N, Cowie MR, et al
    Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure.
    Heart. 2016 Jul 13. pii: heartjnl-2015-308883. doi: 10.1136/heartjnl-2015-308883
    PubMed     Text format     Abstract available


  70. GIJSBERTS CM, Benson L, Dahlstrom U, Sim D, et al
    Ethnic differences in the association of QRS duration with ejection fraction and outcome in heart failure.
    Heart. 2016 Jul 11. pii: heartjnl-2015-309212. doi: 10.1136/heartjnl-2015-309212
    PubMed     Text format     Abstract available


  71. BURDEN A
    QRS duration and ethnicity: implications for heart failure therapy.
    Heart. 2016 Jul 11. pii: heartjnl-2016-309760. doi: 10.1136/heartjnl-2016-309760
    PubMed     Text format    


  72. LIPWORTH B, Skinner D, Devereux G, Thomas V, et al
    Underuse of beta-blockers in heart failure and chronic obstructive pulmonary disease.
    Heart. 2016 Jul 5. pii: heartjnl-2016-309458. doi: 10.1136/heartjnl-2016-309458.
    PubMed     Text format     Abstract available


    June 2016
  73. ENDRIGHI R, Waters AJ, Gottlieb SS, Harris KM, et al
    Psychological stress and short-term hospitalisations or death in patients with heart failure.
    Heart. 2016 Jun 29. pii: heartjnl-2015-309154. doi: 10.1136/heartjnl-2015-309154
    PubMed     Text format     Abstract available


  74. SCALA O, Paolillo S, Formisano R, Pellegrino T, et al
    Sleep-disordered breathing, impaired cardiac adrenergic innervation and prognosis in heart failure.
    Heart. 2016 Jun 23. pii: heartjnl-2015-309215. doi: 10.1136/heartjnl-2015-309215
    PubMed     Text format     Abstract available


  75. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Text format     Abstract available


  76. OTTO CM, Rahimi K
    Heartbeat: The gut microbiota and heart failure.
    Heart. 2016;102:811-2.
    PubMed     Text format    


    May 2016
  77. HAUSER JA, Demyanets S, Rusai K, Goritschan C, et al
    Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Heart. 2016 May 24. pii: heartjnl-2016-309460. doi: 10.1136/heartjnl-2016-309460
    PubMed     Text format     Abstract available


  78. JHUND PS, McMurray JJ
    The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan.
    Heart. 2016 May 20. pii: heartjnl-2014-306775. doi: 10.1136/heartjnl-2014-306775
    PubMed     Text format     Abstract available


    March 2016
  79. TANG WW, Hazen SL
    Dietary metabolism, gut microbiota and acute heart failure.
    Heart. 2016 Mar 15. pii: heartjnl-2016-309268. doi: 10.1136/heartjnl-2016-309268
    PubMed     Text format    


  80. WONG FK, Ng AY, Lee PH, Lam PT, et al
    Effects of a transitional palliative care model on patients with end-stage heart failure: a randomised controlled trial.
    Heart. 2016 Mar 11. pii: heartjnl-2015-308638. doi: 10.1136/heartjnl-2015-308638
    PubMed     Text format     Abstract available


  81. BULLUCK H, Yellon DM, Hausenloy DJ
    Reducing myocardial infarct size: challenges and future opportunities.
    Heart. 2016;102:341-8.
    PubMed     Text format     Abstract available


    February 2016
  82. CLARK AM, Wiens K, Banner D, Kryworuchko J, et al
    A systematic review of the main mechanisms of heart failure disease management interventions.
    Heart. 2016 Feb 23. pii: heartjnl-2015-308551. doi: 10.1136/heartjnl-2015-308551
    PubMed     Text format     Abstract available


  83. PRIOR DL
    Back to the future: re-evaluation of the possible role for oxygen supplementation during exercise in chronic heart failure.
    Heart. 2016 Feb 18. pii: heartjnl-2015-309192. doi: 10.1136/heartjnl-2015-309192
    PubMed     Text format    


  84. KOSHY A, Pellicori P, Clark AL
    The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure.
    Heart. 2016 Feb 18. pii: heartjnl-2015-308932. doi: 10.1136/heartjnl-2015-308932
    PubMed     Text format     Abstract available


  85. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.
    PubMed     Text format    


  86. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.
    PubMed     Text format    


  87. SUZUKI T, Heaney LM, Bhandari SS, Jones DJ, et al
    Trimethylamine N-oxide and prognosis in acute heart failure.
    Heart. 2016 Feb 11. pii: heartjnl-2015-308826. doi: 10.1136/heartjnl-2015-308826
    PubMed     Text format     Abstract available


  88. REANT P, Mirabel M, Lloyd G, Peyrou J, et al
    Global longitudinal strain is associated with heart failure outcomes in hypertrophic cardiomyopathy.
    Heart. 2016 Feb 8. pii: heartjnl-2015-308576. doi: 10.1136/heartjnl-2015-308576.
    PubMed     Text format     Abstract available


  89. CUBBON RM, Witte KK, Kearney LC, Gierula J, et al
    Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification.
    Heart. 2016 Feb 8. pii: heartjnl-2015-308939. doi: 10.1136/heartjnl-2015-308939.
    PubMed     Text format     Abstract available


    January 2016
  90. KWAN GF, Jean-Baptiste W, Cleophat P, Leandre F, et al
    Descriptive epidemiology and short-term outcomes of heart failure hospitalisation in rural Haiti.
    Heart. 2016;102:140-6.
    PubMed     Text format     Abstract available


  91. IACOBAZZI D, Suleiman MS, Ghorbel M, George SJ, et al
    Cellular and molecular basis of RV hypertrophy in congenital heart disease.
    Heart. 2016;102:12-7.
    PubMed     Text format     Abstract available


    December 2015
  92. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Text format     Abstract available


  93. MCKENZIE GA, Porter B, Kaprielian R
    An 89-year-old man presents with worsening heart failure.
    Heart. 2015 Dec 29. pii: heartjnl-2015-308725. doi: 10.1136/heartjnl-2015-308725
    PubMed     Text format    


  94. FRANSSEN C, Chen S, Hamdani N, Paulus WJ, et al
    From comorbidities to heart failure with preserved ejection fraction: a story of oxidative stress.
    Heart. 2015 Dec 16. pii: heartjnl-2015-307787. doi: 10.1136/heartjnl-2015-307787
    PubMed     Text format    


  95. CUBBON RM, Ruff N, Groves D, Eleuteri A, et al
    Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure.
    Heart. 2015 Dec 16. pii: heartjnl-2015-308428. doi: 10.1136/heartjnl-2015-308428
    PubMed     Text format     Abstract available


  96. MACIVER DH, Clark AL
    The key role of the RV in the pathogenesis of acute pulmonary oedema.
    Heart. 2015;101:1929-30.
    PubMed     Text format    


    November 2015
  97. TIETJENS J, Teerlink JR
    Serelaxin and acute heart failure.
    Heart. 2015 Nov 24. pii: heartjnl-2014-306786. doi: 10.1136/heartjnl-2014-306786
    PubMed     Text format     Abstract available


  98. LEE JF, Barrett-O'Keefe Z, Garten RS, Nelson AD, et al
    Evidence of microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2015 Nov 13. pii: heartjnl-2015-308403. doi: 10.1136/heartjnl-2015-308403
    PubMed     Text format     Abstract available


  99. MARTINEZ-GONZALEZ MA, Ruiz-Canela M
    Preventing heart failure: sweetened beverages and healthy lifestyles.
    Heart. 2015 Nov 2. pii: heartjnl-2015-308426. doi: 10.1136/heartjnl-2015-308426.
    PubMed     Text format    


  100. RAHMAN I, Wolk A, Larsson SC
    The relationship between sweetened beverage consumption and risk of heart failure in men.
    Heart. 2015 Nov 2. pii: heartjnl-2015-307542. doi: 10.1136/heartjnl-2015-307542.
    PubMed     Text format     Abstract available


  101. OTTO CM
    Heartbeat: Highlights from this issue.
    Heart. 2015;101:1769-70.
    PubMed     Text format    


  102. KRAMER DB, Hatfield LA, Normand SL
    Comparative effectiveness of cardiac implantable electrical devices.
    Heart. 2015;101:1773-5.
    PubMed     Text format    


  103. KANG DH
    Timing of surgery in infective endocarditis.
    Heart. 2015;101:1786-91.
    PubMed     Text format     Abstract available


  104. WOODS B, Hawkins N, Mealing S, Sutton A, et al
    Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.
    Heart. 2015;101:1800-6.
    PubMed     Text format     Abstract available


    October 2015
  105. GUNDERSEN GH, Norekval TM, Haug HH, Skjetne K, et al
    Adding point of care ultrasound to assess volume status in heart failure patients in a nurse-led outpatient clinic. A randomised study.
    Heart. 2015 Oct 5. pii: heartjnl-2015-307798. doi: 10.1136/heartjnl-2015-307798.
    PubMed     Text format     Abstract available


    September 2015
  106. REINSTADLER SJ, Baum A, Rommel KP, Eitel C, et al
    ST-segment depression resolution predicts infarct size and reperfusion injury in ST-elevation myocardial infarction.
    Heart. 2015 Sep 18. pii: heartjnl-2015-307876. doi: 10.1136/heartjnl-2015-307876
    PubMed     Text format     Abstract available


  107. BOSSEAU C, Galli E, Donal E
    Prognostic value of BNP in heart failure with preserved or reduced EJ.
    Heart. 2015 Sep 11. pii: heartjnl-2015-308515. doi: 10.1136/heartjnl-2015-308515
    PubMed     Text format    


  108. ERDEI T, Aakhus S, Marino P, Paulus WJ, et al
    Pathophysiological rationale and diagnostic targets for diastolic stress testing.
    Heart. 2015;101:1355-60.
    PubMed     Text format     Abstract available


  109. CLELAND JG, Freemantle N
    QRS morphology as a predictor of the response to cardiac resynchronisation therapy: fact or fashion?
    Heart. 2015;101:1441-3.
    PubMed     Text format    


    August 2015
  110. KANG SH, Park JJ, Choi DJ, Yoon CH, et al
    Prognostic value of NT-proBNP in heart failure with preserved versus reduced EF.
    Heart. 2015 Aug 28. pii: heartjnl-2015-307782. doi: 10.1136/heartjnl-2015-307782
    PubMed     Text format     Abstract available


  111. DEVORE AD, Hernandez AF
    Measuring heart failure quality: does perfection matter?
    Heart. 2015 Aug 3. pii: heartjnl-2015-308185. doi: 10.1136/heartjnl-2015-308185.
    PubMed     Text format    


  112. FUCHS FD, Martinez D
    Obstructive sleep apnoea should be deemed a cardiovascular disease.
    Heart. 2015;101:1261-2.
    PubMed     Text format    


  113. COSTA LE, Uchoa CH, Harmon RR, Bortolotto LA, et al
    Potential underdiagnosis of obstructive sleep apnoea in the cardiology outpatient setting.
    Heart. 2015;101:1288-92.
    PubMed     Text format     Abstract available


    June 2015
  114. VIAU DM, Sala-Mercado JA, Spranger MD, O'Leary DS, et al
    The pathophysiology of hypertensive acute heart failure.
    Heart. 2015 Jun 29. pii: heartjnl-2015-307461. doi: 10.1136/heartjnl-2015-307461
    PubMed     Text format     Abstract available


  115. BOTTLE A, Goudie R, Cowie MR, Bell D, et al
    Relation between process measures and diagnosis-specific readmission rates in patients with heart failure.
    Heart. 2015 Jun 11. pii: heartjnl-2014-307328. doi: 10.1136/heartjnl-2014-307328
    PubMed     Text format     Abstract available


  116. BRIASOULIS A, Mallikethi-Reddy S, Palla M, Alesh I, et al
    Myocardial fibrosis on cardiac magnetic resonance and cardiac outcomes in hypertrophic cardiomyopathy: a meta-analysis.
    Heart. 2015 Jun 9. pii: heartjnl-2015-307682. doi: 10.1136/heartjnl-2015-307682.
    PubMed     Text format     Abstract available


  117. JOHANSSON I, Dahlstrom U, Edner M, Nasman P, et al
    Risk factors, treatment and prognosis in men and women with heart failure with and without diabetes.
    Heart. 2015 Jun 1. pii: heartjnl-2014-307131. doi: 10.1136/heartjnl-2014-307131.
    PubMed     Text format     Abstract available


  118. PATEL V, O'Mahony C, Hughes D, Rahman MS, et al
    Clinical and genetic predictors of major cardiac events in patients with Anderson-Fabry Disease.
    Heart. 2015;101:961-6.
    PubMed     Text format     Abstract available


    May 2015
  119. PELLICORI P, Kallvikbacka-Bennett A, Dierckx R, Zhang J, et al
    Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure.
    Heart. 2015 May 25. pii: heartjnl-2015-307558. doi: 10.1136/heartjnl-2015-307558
    PubMed     Text format     Abstract available


  120. DELGADO V, Bax JJ
    Diastolic dysfunction and atrial fibrillation.
    Heart. 2015 May 18. pii: heartjnl-2015-307885. doi: 10.1136/heartjnl-2015-307885
    PubMed     Text format    


  121. TATEISHI E, Noguchi T, Goto Y, Morita Y, et al
    Prognostic impact of blood pressure response plus gadolinium enhancement in dilated cardiomyopathy.
    Heart. 2015;101:774-80.
    PubMed     Text format     Abstract available


  122. TIWARI S, Schirmer H, Jacobsen BK, Hopstock LA, et al
    Association between diastolic dysfunction and future atrial fibrillation in the Tromso Study from 1994 to 2010.
    Heart. 2015 May 13. pii: heartjnl-2015-307438. doi: 10.1136/heartjnl-2015-307438
    PubMed     Text format     Abstract available


    March 2015
  123. HOLMQVIST F, Kim S, Steinberg BA, Reiffel JA, et al
    Heart rate is associated with progression of atrial fibrillation, independent of rhythm.
    Heart. 2015 Mar 2. pii: heartjnl-2014-307043. doi: 10.1136/heartjnl-2014-307043.
    PubMed     Text format     Abstract available


    October 2014
  124. MAGNE J, Donal E, Mahjoub H, Miltner B, et al
    Impact of exercise pulmonary hypertension on postoperative outcome in primary mitral regurgitation.
    Heart. 2014 Oct 17. pii: heartjnl-2014-306296. doi: 10.1136/heartjnl-2014-306296
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: